India is the world’s third largest country affected with new cases of cancer at 7%, after the US and China. Cancer accounts for 8% of the main causes of death through disease in India. The key areas of focus in oncology in India are breast cancer, colorectal cancer, lung cancer, NHL and prostate cancer. The combined market was $153 million with a compounded growth of 12.7% from 2004. It is expected to grow at a compounded rate of 6.5% pa to $ 240 million by 2018.

UK Trade & Investment (UKTI) is organising a trade mission to India for UK companies active in Oncology. This delegation will help you understand and explore the market and identify ways and partners for engaging with India. The mission will visit Mumbai, Bangalore and Chennai between the 1st and 7th of September 2013. The British Deputy High Commission in Mumbai, Bangalore and Chennai will organise programmes which will include seminars, networking receptions, one to one meetings and company visits in all cities and the Indo British Health Initiative (IBHI) in Chennai (for further details: http://ibhi.in/wp-content/uploads/2013/05/IBHI Indo_UK-Oncology-Summit-Preliminary-Invite.pdf)

Who should participate?

If you are a UK organisation working on oncology interested in, research and development, platform technologies, genome sequencing, services for oncology, medical devices, diagnostics, academia then you should be a part of this delegation.

Full details see here: 34917 Life Science India flierV2

For more information on the mission please contact Priya Varadarajan and Namrata Devalla:
Priya.varadarajan@fco.gov.uk
Namrata.Devalla@fco.gov.uk